Profilo
Jordi Xiol is currently a Partner at Ysios Capital Partners SGEIC SA since 2019.
He is also a Board Member at NorthSea Therapeutics BV since 2021 and at SpliceBio SL since 2023.
Mr. Xiol completed his undergraduate degree at the University of Barcelona in 2007 and obtained a doctorate from The European Molecular Biology Laboratory.
Posizioni attive di Jordi Xiol
| Società | Posizione | Inizio |
|---|---|---|
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Investitore di Private Equity | 01/06/2021 |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Direttore/Membro del Consiglio | 01/01/2023 |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Direttore/Membro del Consiglio | 01/12/2021 |
Formazione di Jordi Xiol
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Barcelona
University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The European Molecular Biology Laboratory
The European Molecular Biology Laboratory Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ysios Capital Partners SGEIC SA
Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital invests in companies located across the globe. The firm targets companies operating in the fields of the biotechnology sector. It provides financing for early and growth stage capital requirements. | Finance |
NorthSea Therapeutics BV
NorthSea Therapeutics BV BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel strategies for the treatment of metabolic, inflammatory and fibrotic diseases | Health Technology |
SpliceBio SL
SpliceBio SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















